InsidersTradesSigma
에임드바이오 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 에임드바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에임드바이오 has published 3 public disclosures. Market capitalisation: €1,745bn. The latest transaction was disclosed on 17 March 2026 (Sale). Among the most active insiders: 인터베스트. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€69m
2 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 March 2026